A vaccine manufacturing company was caught on record, confirming that everyone taking the vaccine was part of a clinical trial.
A segment of a phone call was obtained by the Stew Peters Show.
The phone call was made by a woman who suffered Guillain-Barre syndrome after being administered with the Moderna vaccine. Her doctor believes that her condition was directly linked to the vaccine. So she decided to call the company for an explanation.
“The vaccines are still in the clinical trials right?” she asked.
“The Moderna COVID-19 vaccine has not been approved or licensed by the Food and Drug Administration, but it has been authorized for emergency use by the FDA under an emergency use authorization to prevent coronavirus disease 2019, for use in individuals 18 years of age and older,” the representative responded with a disclaimer.
“There is no FDA-approved vaccine to prevent COVID-19. The EUA for the Moderna COVID-19 vaccine is in effect for the duration of the COVID-19 EUA declaration, justifying emergency use of the product unless that declaration is terminated or the authorization is revoked sooner,” he continued.
“Is everyone that’s getting the vaccines in the clinical trial or is it only some of the vaccines are in the clinical trials? I’m very confused on that.” the woman asked.
Moderna’s representative stated that all of the company’s clinical trial phases were still underway, and that the vaccine’s long-term protective efficacy was unknown.
“OK so everybody who’s getting these vaccines right now is in the clinical trials. It’s not like some of us got it and some of us didn’t, like, everyone who’s getting it is participating in the clinical trial?” she continued.
“Er… Pretty much, I mean… Yeah…”, the representative replied.
Guillain-Barre syndrome is a condition caused by an autoimmune disorder. It triggers the immune system to assault the body’s own nerves. Weakness and tingling sensations in the extremities are the initial signs. The symptoms spread quickly, finally resulting in total bodily paralysis.
According to Humans are Free, other COVID-19 vaccines are also causing Guillain-Barre syndrome in people who get the shots. For example, the outlet reported an adverse reaction case of Rebeca Cruz-Esteves, a Manayunk resident in Philadelphia who suffered Guillain-Barre syndrome after her first dose of the Pfizer COVID vaccine on March 17.
Less than 15 minutes after the vaccine injection, the 31-year-old mom had an anaphylactic reaction: chest and throat tightness, heart palpitations, and a skin rash on her chest. Later on she had strange experiences like muscle spasms, stiffness in her legs and she was also unexplainably hyperactive.
“I couldn’t sleep,” she added. “It was like electricity was running through my body, this jolt … and I couldn’t feel fatigue, which was very strange.”
Cruz-Esteves has been admitted to the hospital twice since she developed adverse symptoms.
“I’ve been in and out of the hospital. I haven’t really been able to work. I had just returned back from maternity leave when this happened, so I had only been at work for three days. We have medical bills coming in [that] we don’t know if we can afford,” she said.
“I haven’t seen my daughter for two weeks,” Cruz-Esteves said in tears. “My dad had to fly out from Puerto Rico to help my husband … because of the pandemic, we can’t really get the help that we need from everyone, so my husband’s been alone with the baby for this entire time.”
Cruz-Esteves is on the edge of losing her job as military member in field artillery combat arms—the job she has been doing for nine years—since her health condition is no longer suitable to the job requirements.